Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
99,016,334
-
Share change
-
+3,387,371
-
Total reported value
-
$55,690,000
-
Put/Call ratio
-
808%
-
Price per share
-
$0.56
-
Number of holders
-
90
-
Value change
-
-$10,165,671
-
Number of buys
-
36
-
Number of sells
-
57
Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q1 2016
As of 31 Mar 2016,
OREXIGEN THERAPEUTICS INC - COM (OREX) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
99,016,334 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, FMR LLC, Foresite Capital Management II, LLC, SAMLYN CAPITAL, LLC, BlackRock Fund Advisors, MORGAN STANLEY, FRANKLIN RESOURCES INC, NEA Management Company, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
90
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.